Skip to main content
. 2011 Jun;31(12):2528–2542. doi: 10.1128/MCB.01285-10

Table 3.

ChIP-seq design and results

Sample Strain Genotype Antibodya Exptb No. of reads No. of mapped reads % mapped
CenH3 NMF241 WTc Anti-GFP HTS41 22,648,972 1,868,888 8
NMF166 WT Anti-GFP HTS114d 5,765,823 5,115,507 89
NMF233 WT Anti-GFP HTS115d 3,396,810 2,991,616 88
    Total 31,811,605 9,976,011 31
NMF239 dim-5 Anti-GFP HTS61 941,134 831,702 88
NMF239 dim-5 Anti-GFP HTS76 1,945,259 1,361,074 70
    Total 2,886,393 2,192,776 76
NMF232 hpo Anti-GFP HTS42 23,465,182 2,824,712 12
CEN-C NMF225 WT Anti-GFP HTS125 16,749,444 14,853,136 89
CEN-T NMF399 WT Anti-GFP HTS118d 3,584,558 1,842,613 51
H3K4me2 NMF229 WT Anti-H3 K4me2 HTS14 6,978,488 3,620,059 52
H3K4me3 NMF39 WT Anti-H3 K4me3 HTS62 1,265,661 1,180,098 93
NMF39 WT Anti-H3 K4me3 HTS77 11,944,378 10,021,030 84
    Total 13,209,739 11,201,128 85
H3K9me3 NMF39 WT Anti-H3 K9me3 HTS111 14,638,703 12,672,192 87
NMF166 WT Anti-H3 K9me3 HTS120d 4,818,433 4,229,931 88
MeDIP NMF39 WT Anti-5meC HTS18 4,588,332 1,713,181 37
a

Antibodies used: anti-GFP, Abcam ab290; anti-H3K4me2, Upstate 07-030; anti-H3K4me3, Active Motif AR-0169; anti-H3 K9me3, Active Motif 39161; anti-5me-C, Diagenode MAb-5MECYT-100.

b

Experiment names were used to submit data to the FFGED (see Materials and Methods).

c

WT, wild type.

d

Adapter sequence indicated for samples that were multiplexed: HTS114, ACGT; HTS115, CTGT; HTS118, CCCT; HTS120, GCTT.